Abstract
With declining R&D productivity and maturing product portfolios, maximizing
revenues through lifecycle management has never been more important for
pharmaceutical companies. Upon patent expiry, companies risk losing up to 80%
of brand sales, highlighting the importance of implementing successful
strategies for brand protection and market expansion. Maximize revenue at all
stages of the product lifecycle and minimize the impact of generic competition
on your brand with the help of this new management report. 'Lifecycle
Management Strategies' is a new management report which provides practical
solutions to tackle the loss of market share to generic competition at patent
expiry. Strategies including Rx-to-OTC switching, indication expansion and
reformulation are evaluated in terms of product and developer characteristics,
economic viability and regulatory compliance. This will ensure that you are
able to select a strategy that will maximize return on investment and sustain
brand loyalty.
View Cart
